Calidi Biotherapeutics (CLDI) Non Operating Interest Expenses (2022 - 2026)
Calidi Biotherapeutics' Non Operating Interest Expenses came in at $35,000 for Q2 2026, down 32.7% from $52,000 a year earlier.
Powered by 
Analysis
Calidi Biotherapeutics (CLDI) Non Operating Interest Expenses (2022 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Calidi Biotherapeutics reported Non Operating Interest Expenses of $170,000, down 68.0% year-over-year; for FY2025, it was $207,000, down 77.8% from FY2024.
- Non Operating Interest Expenses carries a three-year compound annual growth rate of 1.2% (FY2022 to FY2025).
- Going back by year, Non Operating Interest Expenses was $933,000 in FY2024 (-15.2%), $1.1 million in FY2023 (+450.0%) and $200,000 in FY2022.
- The Q2 2026 figure represents the lowest quarterly Non Operating Interest Expenses since Q3 2022.
- The fastest year-over-year change in Non Operating Interest Expenses over five years came in Q3 2023 (growth of 934.5%), and the weakest in Q3 2025 (a decline of 82.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Calidi Biotherapeutics | 1.50 Mn | -23.88 Mn | - | 35,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 35,000.00 |
| Dec 31, 2025 | 42,000.00 |
| Sep 30, 2025 | 41,000.00 |
| Jun 30, 2025 | 52,000.00 |
| Mar 31, 2025 | 72,000.00 |
| Dec 31, 2024 | 175,000.00 |
| Sep 30, 2024 | 232,000.00 |
| Jun 30, 2024 | 273,000.00 |
| Mar 31, 2024 | 300,000.00 |
| Dec 31, 2023 | 300,000.00 |
| Sep 30, 2023 | 300,000.00 |
| Jun 30, 2023 | 306,000.00 |
| Mar 31, 2023 | 200,000.00 |
| Dec 31, 2022 | 100,000.00 |
| Sep 30, 2022 | 29,000.00 |
API Access
Calidi Biotherapeutics Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=CLDI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "CLDI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=CLDI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();